Logo image
Evolving Roles of Fluorodeoxyglucose and Sodium Fluoride in Assessment of Multiple Myeloma Patients Introducing a Novel Method of PET Quantification to Overcome Shortcomings of the Existing Approaches
Journal article   Open access

Evolving Roles of Fluorodeoxyglucose and Sodium Fluoride in Assessment of Multiple Myeloma Patients Introducing a Novel Method of PET Quantification to Overcome Shortcomings of the Existing Approaches

Mahdi Zirakchian Zadeh, William Y. Raynor, Siavash Mehdizadeh Seraj, Cyrus Ayubcha, Esha Kothekar, Thomas Werner and Abass Alavi
PET clinics, v 14(3), pp 341-352
01 Jul 2019
PMID: 31084774
url
https://findresearcher.sdu.dk/ws/files/170260296/NaF_MM_Pre_Post_EJNM_R1.pdfView

Abstract

Life Sciences & Biomedicine Radiology, Nuclear Medicine & Medical Imaging Science & Technology
PET with fluorodeoxyglucose and sodium fluoride (NaF) radiotracers has shown a great promise in assessing patients with multiple myeloma (MM). However, the standardization of PET/computed tomography scans interpretation in patients with myeloma in clinical practice is still debatable. This article reviews available data regarding the use of fluorodeoxyglucose and NaF PET in patients with MM. Introduced is a novel method of PET quantification as applied to patients with MM. A new concept for PET-based evaluation of patients with MM is also discussed: dual time point imaging. Finally, the role of NaF in assessment of cardiovascular complications of MM is described.

Metrics

9 Record Views
17 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Radiology, Nuclear Medicine & Medical Imaging
Logo image